Science

M104AI

Inflammatory bowel disease treatment M104AI

Discovery
PoC/MoA
Lead
Optimization
CMC
GLP TOX
Clinical PhI

Inflammatory bowel disease, represented by Crohn's disease and ulcerative colitis, is a chronic idiopathic autoimmune disease characterized by loss of the intestinal mucosa of the gastrointestinal tract, submucosal inflammation, edema, and bleeding.

Current treatment for IBD, such as immunosuppressants have side effects such as bone marrow suppression and decreased immune cell count.